Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03455829 |
| Title | G1T38, a CDK 4/6 Inhibitor, in Combination With Osimertinib in EGFR-Mutant Non-Small Cell Lung Cancer |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | G1 Therapeutics, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Beverly Hills Cancer Center | Beverly Hills | California | 90211 | United States | Details | |
| UCLA Medical Center, Division of Hematology/Oncology/Clinical Research Unit | Santa Monica | California | 90404 | United States | Details | |
| St Joseph Heritage Healthcare | Santa Rosa | California | 95403 | United States | Details | |
| Sylvester Comprehensive Cancer Center/University of Miami Miller School of Medicine Fox Building, Suite 200 G | Miami | Florida | 33136 | United States | Details | |
| Mofitt Cancer Center | Tampa | Florida | 33612 | United States | Details | |
| Univ. of Michigan Hospitals | Ann Arbor | Michigan | 48109 | United States | Details | |
| Virginia Cancer Specialists | Fairfax | Virginia | 22301 | United States | Details | |
| Froedtert Hospital & the Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | United States | Details |